(Yicai Global) Sept. 18 -- Eleven potential Covid-19 vaccines have entered clinical trials in China, four of which have entered phase III testing, Beijing Daily reported today, citing Wang Zhigang, minister of Science and Technology.

Medical professionals are advancing research and development using inactivated, adenovirus vector, recombinant protein, nucleic acid and attenuated influenza vaccines, Wang explained.

Phase III involves randomized testing of from 300 to 3,000 subjects with the ailment a new pharmaceutical targets.

Editor: Ben Armour